171
Views
9
CrossRef citations to date
0
Altmetric
Research Articles

An Exploration of Site Effects in a Multisite Trial of OROS-Methylphenidate for Smokers with Attention Deficit/Hyperactivity Disorder

, Ph.D., , Ph.D., , Ph.D., M.P.H., , Ph.D., , M.D., , M.D. & , Ph.D. show all
Pages 392-399 | Published online: 22 Aug 2011

REFERENCES

  • Friedman LM, Furberg CD, DeMetz DL. Multicenter trials. In Fundamentals of Clinical Trials. St. Louis, MO: Mosby-Yearbook, Inc., 1985; 285–298.
  • Nunes EV, Ball S, Booth R, Brigham G, Calsyn DA, Carroll K, Feaster DJ, Hien D, Hubbard RL, Ling W, Petry NM, Rotrosen J, Selzer J, Stitzer M, Tross S, Wakim P, Winhusen T, Woody G. Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: Have we chosen the best designs? J Subst Abuse Treat 2010; 38(Suppl. 1):S97–S112.
  • Ioannidis JPA, Dixon DO, McIntosh M, Albert JM, Bozzette SA, Schnittman SM. Relationship between event rates and treatment effects in clinical site differences within multicenter trials: An example from Primary Pneumocystis carinii Prophylaxis. Control Clin Trials 1999; 20:253–266.
  • Kraemer HC. Pitfalls of randomized clinical trials of efficacy and effectiveness. Schizophr Bull 2000; 26:533–541.
  • March J, Kraemer HC, Trivedi M, Csernansky J, Davis J, Ketter TA, Glick ID. What have we learned about trial design from NIMH-funded pragmatic trials? Neuropsychopharmacology 2010; 35:2491–2501.
  • Winhusen TM, Somoza EC, Brigham GS, Liu DS, Green CA, Covey LS, Croghan IT, Adler LA, Weiss RD, Leimberger JD, Lewis DF, Dorer EM. Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: A randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2010; 71:1680–1688.
  • Adler LA, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 2004; 7:187–201.
  • Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: Issues and recommendations. Nicotine Tob Res 2003; 5:13–25.
  • Sobell LC, Sobell MB. (1992). Timeline Follow-back: A technique for assessing self-reported ethanol consumption. In Allen J, Litten RZ, ( Eds.), Measuring Alcohol Consumption: Psychosocial and Biological Methods (pp. 41–72). Totowa, NJ: Humana Press.
  • Jarvis MJ, Tunsall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y. Comparison of tests to distinguish smokers from nonsmokers. Am J Publ Health 1987; 77:1435–1438.
  • Adler LA, Spencer T, Faraone SV. Training raters to assess adult ADHD: Reliability ratings. J Atten Disord 2005; 8:121–126.
  • Moolchan ET, Radzius A, Epstein DH, Uhl G, Gorelick DA, Cadet JL, Henningfield JE. The Fagerstrom test for nicotine dependence and the diagnostic interview schedule: Do they diagnose the same smokers? Addict Behav 2002; 27:101–113.
  • Brown H, Prescott, R. Applied Mixed Models in Medicine (2nd ed.). Hoboken, NJ: John Wiley & Sons, 2006.
  • Berlin I, Chen H, Covey LS. Depressive mood, suicide ideation, and anxiety in smokers who do and smokers who do not manage to stop smoking after a target quit day. Addiction 2010; 105:2209–2216.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.